HOME >> BIOLOGY >> NEWS
Duke ecologist's book offers hopeful view of Earth's plight

DURHAM, N.C. -- As described by ecologist Rob Jackson in his new book "The Earth Remains Forever," ours is a planet that is losing species at more than 100 times the average historical rate as reflected in the fossil record.

It is also a planet where the population of six billion humans increases by another billion about every 12 years; where farmers pour billions of pounds of pesticides into its soils each year; and that has, in the last three decades, lost a million and a half square miles of forest, the equivalent of all the forest lands in North America today.

As Jackson, an associate professor of biology at Duke University, lays out a stunning litany of facts about the damaging human impact on Earth, he also emphasizes the importance of preserving the natural world -- citing, for example, the fact that more than 40 percent of all pharmaceuticals are derived from "nature's medicine cabinet" (plants, animals and microbes).

Even as he uses stark facts to build a case for immediate action to remedy global environmental problems, Jackson has emerged from the experience of writing the book with hope that these problems can be solved.

"In some cases, my research for the book showed that some situations were not as desperate as I had thought previously," he said in an interview. "While we do have very serious ecological problems to solve, I don't believe that the 'catastrophization' of science is helpful."

Catastrophization, he explained, occurs when "people sometimes use bad environmental news to further an agenda, and even through I feel strongly about the importance of protecting the environment, it's a dangerous game to play. It results in genuinely bad news being swamped by 'pretend' bad news."

For that reason, said Jackson, he wrote "The Earth Remains Forever" (University of Texas Press) to offer the public an accessible, realistic source of information about global environmental problems and approaches to sol
'"/>

Contact: Dennis Meredith
dennis.meredith@duke.edu
919-681-8054
Duke University
17-Oct-2002


Page: 1 2 3 4

Related biology news :

1. Lake research offers clues to managing crayfish invasions
2. Comparing primate genomes offers insight into human evolution
3. Study of proteins offers insights into organization of biological networks
4. Susceptibility of mice to mousepox offers promise of smallpox protection
5. Botulinum toxin structure offers clues for vaccines/treatments
6. Discovery offers clues to origin of life
7. Guiding gas exploration: U-M research offers inexpensive tool
8. New approach offers potential drug-discovery shortcut
9. American Society of Plant Biologists offers developing nations free access to science journals
10. Study offers new model for breast cancer
11. Rutgers researcher offers a new perspective on human evolution

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Duke ecologist book offers hopeful view Earth plight

(Date:5/6/2015)... , May 6, 2015 LifeBEAM, a developer ... helmet producer, announced today that they will expand their ... world,s first bio-sensing cycling helmet and the first joint ... two new colors in order to give cyclists more ... In addition, LifeBEAM and Lazer announced their plan to ...
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
(Date:4/20/2015)... 20, 2015 Huntington Memorial Hospital is the ... a new miniaturized, wireless monitoring sensor to manage heart ... and only FDA-approved heart failure monitoring device that has ... by physicians to manage heart failure. The ... in the pulmonary artery (PA) during a non-surgical procedure ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
(Date:5/22/2015)... 2015  Actavis plc (NYSE: ACT ) today ... Appeals for the Second Circuit has issued a ruling ... Company to continue distribution of NAMENDA ® (memantine ...   "While we are disappointed by ... to continue our strong efforts to convey the significant ...
(Date:5/21/2015)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... and commercializes proprietary technologies and products for advanced microarray ... the second fiscal quarter ended March 31, 2015. ... advance business with our existing customers and to develop ... CEO of SQI. "The delivery of a fully automated ...
(Date:5/21/2015)... 2015 uBiome, the leading startup ... with PicnicHealth, a healthcare company that collects and ... Inflammatory Bowel Disease (IBD) will receive a complementary ... research kit. Both companies were funded by Y ... For more information on this partnership and how ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
Breaking Biology Technology:Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
Cached News: